Light therapy offers new hope for esophageal cancer patients
NCT ID NCT06437288
First seen May 23, 2026 · Last updated May 23, 2026
Summary
This study tests a treatment called photodynamic therapy (PDT) for people whose superficial esophageal cancer has come back or remained after prior treatments. Patients receive a drug that makes cancer cells sensitive to light, then a laser is used to destroy them. The goal is to see how many patients have their tumors completely disappear by day 56. About 198 adults aged 18-80 will take part.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Endoscopic Department of Sun Yat-Sen University Cancer Center
Guangzhou, Guangdong, 510060, China
Conditions
Explore the condition pages connected to this study.